ScholarWorks@Korea University: Park, Chang Gyu

Detailed Information

Park, Chang Gyu (박창규)

College of Medicine (Department of Medical Science)

Research Area

Tel 구3019
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

hypertension:24||blood pressure:9||Coronary artery spasm:8||coronary artery spasm:7||atrial fibrillation:7||Percutaneous coronary intervention:6||acetylcholine:6||Acetylcholine:6||Hypertension:6||amlodipine:5||losartan:5||Acute myocardial infarction:5||percutaneous coronary intervention:5||coronary artery disease:4||Drugeluting stent:4||Coronary artery disease:4||Type 2 Diabetes:4||Asia:4||catheter ablation:4||Creactive protein:3||Sirolimuseluting stents:3||angiotensin receptor blocker:3||Acetylcholine provocation test:3||metabolic syndrome:3||irbesartan:3||carotid intimamedia thickness:3||Atrial fibrillation:3||endothelial dysfunction:3||lipoprotein(a):3||combination:3||Risk factors:3||angina:3||Clinical outcomes:3||Angina pectoris:3||singlepill combination:3||left atrium:3||arterial stiffness:3||chronic total occlusion:3||computed tomography:3||rosuvastatin:2||target organ damage:2||coronary angiography:2||epidemiology:2||Diagnosis:2||atorvastatin:2||medical therapy:2||Myocardial bridge:2||Paclitaxeleluting stents:2||platelets:2||pulse wave analysis:2||stents:2||obesity:2||activecontrol equivalence trial:2||Diabetes:2||cardiovascular diseases:2||ezetimibe:2||myocardial infarction:2||Vasospastic angina:2||outcomes:2||Treatment:2||Diabetes mellitus:2||Amlodipine:2||left ventricular mass:2||control:2||Blood pressure:2||Echocardiography:2||diastolic function:2||drugeluting stent:2||diabetes mellitus:2||critical limb ischemia:2||carvedilol:2||Exsmoker:1||Statins:1||intracoronary acetylcholine provocation test:1||Angiotensin II receptor blocker:1||Asian population:1||Left main coronary artery:1||atrial function:1||rosuvastatin calcium:1||Metabolic syndrome:1||Obesity:1||telmisartan:1||Cigarette smoking:1||angiotensin converting enzyme inhibitor:1||safety:1||Atherosclerosis:1||unstable plaque:1||brachialankle pulse wave velocity:1||peripheral transluminal angioplasty:1||angiotensinconverting enzyme inhibitor:1||angiotensinreceptor blocker:1||central blood pressure:1||Impaired fasting glucose:1||ambulatory blood pressure:1||randomized controlled trials:1||Achinduced coronary vasospasm:1||Psychiatric status rating scales:1||control/therapy:1||Antihypertensives:1||peripheral arterial disease:1||Drugeluting stents:1||Drug eluting stent:1||Congenital:1||Coronary vessels:1||multidetector computed tomography:1||synchrotron:1||threedimensional multidetector CT:1||stenosis:1||협심증:1||Type 2 Diabetes Mellitus:1||outcome:1||Chronic total occlusion:1||prediabetes:1||hyperuricaemia:1||Clinical followup:1||nonselective ssblockers:1||bisoprolol:1||ABPM:1||Drug eluting stents:1||Hypertension Blood pressure:1||Vasomotion type:1||Arterial intima:1||hyperlipidemia:1||PAD:1||sarpogrelate:1||Age factor:1||arterial inflammation:1||coronary:1||PTA:1||antihypertensive:1||Adipocyte fatty acid binding protein:1||body mass index:1||StentBoost:1||P2Y(12):1||tolerability:1||Aortic calcification:1||PRASUGREL:1||Guidelines:1||Home monitoring:1||Masked hypertension:1||arteriosclerosis/blood:1||biological markers/blood:1||Coronary anomaly:1||Baremetal stent:1||SES:1||atherosclerosis:1||Glycated Hemoglobin A:1||Sulfonylurea:1||Alcohol:1||selective ss 1blockers:1||STsegment myocardial infarction:1||racial difference:1||clinical followup:1||Central blood pressure:1||drug combinations:1||chronic kidney disease:1||diabetic:1||Chest pain:1||Major clinical outcomes:1||risk stratification:1||Tetralogy of Fallot:1||Linear ablation:1||adipokine:1||lipocalin2:1||body composition:1||index of microvascular resistance:1||clopidogrel bisulfate:1||pulse pressure:1||Lipids:1||Cardiac CT:1||CLOPIDOGREL:1||cytokines:1||epicardial adipose tissue:1||inflammatory:1||Left atrial function:1||Antilipemic agents/therapeutic use:1||Noncardiac surgery:1||Zotarolimuseluting stents:1||DES:1||plaque:1||adjunctive balloon:1||fibroelastosis:1||noncontact mapping:1||Smoking:1||smoking cessation:1||combination therapy:1||generic medicine:1||Intravascular ultrasound:1||epicardial fat:1||Heart rate variability:1||stroke Jcurve:1||antihypertensive agents:1||DPR202:1||Coronary vasospasm:1||Positron emission tomography:1||clopidogrel napadisilate:1||Computed tomography:1||hypertension.:1||Dyslipidemia:1||Home Blood Pressure Monitoring:1||Systolic pressure:1||Stroke:1||remodeling:1||Mean platelet volume:1||Drug effects:1||cilostazol:1||Graft stent:1||unmonochromatized:1||visceral artery aneurysms:1||Hemoglobin A1c:1||LDLC:1||Angina:1||newonset diabetes mellitus:1||Coronary artery stenosis:1||coronary vasospasm:1||Cardiac autonomic dysfunction:1||Samlodipine:1||Clinical outcome:1||vasospasm:1||efficacy:1||urinary sodium:1||Coronary artery:1||Atrial mass:1||Plaque rupture:1||Acute coronary syndromes:1||Carotid arteries:1||Ubiquitin:1||Catheter ablation:1||Myocardial injury:1||Neutrophil/lymphocyte ratio:1||extracellular fluid:1||coronary microvascular function:1||Adiponectin:1||Cohort studies:1||whitecoat effect:1||Diastolic pressure:1||endothelial function:1||Vascular endothelium:1||Coronary disease:1||drug interaction:1||lipoproteins, LDL/blood/chemistry:1||aorta:1||Single coronary artery:1||aortic stiffness:1||tissue Doppler:1||BMS:1||endocardium:1||dyslipidemia:1||circadian pattern:1||fixeddose combination:1||left ventricular hypertrophy:1||air pollution:1||risk factors:1||Angiotensin converting enzyme inhibitor:1||collateral circulation:1||left atrial function:1||multivessel disease:1||Longterm clinical outcome:1||cholesterol:1||Carotid artery:1||BP variability:1||Anplag Tab:1||guideline:1||major adverse cardiac events:1||Peripheral arterial disease:1||valsartan:1||left ventricular function:1||restenosis:1||angiotensin II type 1 receptor:1||global risk evaluation:1||Arteriovenous fistula:1||Complex fractionated atrial electrograms:1||central hemodynamics:1||Acetylcholine dose:1||Aspirin:1||Function:1||fimasartan:1||losartan.:1||Jcurve:1||calcium channel blockers:1||cardiovascular endpoints:1||tissue Doppler imaging:1||Atrial septal aneurysm:1||simvastatin:1||hyperlipidemias/prevention &:1||Cardiovascular diseases:1||Coronary angiography:1||thrombosis:1||bilateral coronary artery fistula:1||apo Eknockout mouse:1||superior mesenteric artery aneurysms:1||acute myocardial infarction:1||drug eluting stent:1||Metformin:1||irreversible effect:1||Myocardial infarction:1||hypercholesterolemia:1||clinical outcomes:1||antihypertensive:1||Vascular aging:1||Diltiazem:1||nitrate:1||Arterial media:1||fixeddose combinations:1||reninangiotensin system:1||calcium channel blocker:1||acute coronary syndrome:1||PET/CT:1||Antiplatelet therapy:1||Critical limb ischemia:1||Peripheral angiography:1||reninangiotensinaldosterone system inhibitor:1||blood sugar control:1||Arteriosclerosis:1||Inflammation:1||Ablation time:1||Left atrium:1||Coronary calcification:1||multivessel coronary artery spasm:1||Valsartan:1||echocardiography:1||left ventricle:1||inflammation:1||arterial pulse wave velocity:1||nonconcurrent dosing:1||coronary artery disease/prevention &:1||lipids:1||aging:1||radial artery:1||Pulse wave velocity:1||blood pressure control:1||Coronary rupture:1||communication between two fistulas:1||thrombolysis in myocardial infarction flow:1||진단:1||치료:1||Hypoglycemia:1||uric acid:1||chlorthalidone:1||sex differences:1||LDL:1||Risk assessment:1||Body size phenotype:1||RAS:1||Gastroesophageal reflux:1||olmesartan:1||lercanidipine:1||amputation:1||Everolimuseluting stents:1||antiplatelet efficacy:1||augmentation index:1||Prevalence:1||Adrenergic betaantagonists:1||prehypertension:1||Cryptogenic stroke:1||Whitecoat effect:1||Depression:1||cytochrome P450:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||particle size:1||Renninangiotensin system:1||pulse wave velocity:1||Arterial stiffness:1||metabolic risk factors:1||Large coronary artery:1||ZES:1||recanalization:1||

STATISTICS: Total View :6,954,483; Today View :20,549

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE